Amelogenin is the major protein component of the forming enamel matrix. In situ hybridization revealed a periodicity for amelogenin mRNA hybridization signals, ranging from low to high transcript abundance on serial sections of developing mouse teeth. This in vivo observation led us to examine the amelogenin promoter for the activity of transcription factor(s) that account for this expression aspect of the regulation for amelogenin gene. We have previously shown that CCAAT/enhancer-binding protein alpha (C/EBP ) is a potent transactivator of the mouse X-chromosomal amelogenin gene acting at the C/EBP cis-element located in the -70/ +52 minimal promoter. The minimal promoter contains a reversed CCAAT box (-58/-54), which is four base pairs downstream from the C/EBP binding site. Similar to the C/EBP binding site, the integrity of the reversed CCAAT box is also required for maintaining the activity of the basal promoter. We therefore focused on transcription factors that interact with the reversed CCAAT box. Using electrophoretic mobility shift assays we demonstrated that NF-Y was directly bound to this reversed CCAAT site. Co-transfection of C/EBP and NF-Y synergistically increased the promoter activity. In contrast, increased expression of NF-Y alone had only marginal effects on the promoter. A dominant-negative DNA binding-deficient NF-Y mutant (NFYAm29) dramatically decreased the promoter activity, both in the absence or presence of exogenous expression of C/EBP . We identified protein-protein interactions between C/EBP with NF-Y by a coimmunoprecipitation analysis. These results suggest that C/EBP and NF-Y synergistically activate the mouse amelogenin gene and can contribute to its physiological regulation during amelogenesis.
Tooth organogenesis is a complex developmental process that is dependent upon a series of reciprocal and instructive signals (1) . These signals culminate to orchestrate expression of the amelogenin gene, the major organic component of the enamel matrix. Amelogenin plays a key role in regulating proper enamel mineralization and is believed to regulate its own replacement by the mineral phase to create a woven hierarchical architecture that accounts for the unique materials properties of enamel (2) (3) (4) (5) . Mutations to the human amelogenin gene have been linked to patients with the inherited enamel defect X-linked amelogenesis imperfecta (6) .
Amelogenin is specifically expressed and secreted by ameloblast cells and this process is tightly controlled spatiotemporally (7) . The murine amelogenin promoter has been isolated from the mouse X-chromosome. Based upon transgenic mouse studies, our lab has demonstrated that the 2263 nucleotides upstream of amelogenin start codon fully recapitulates the endogenous amelogenin gene expression profile within time and space (8) . Deletion analysis of this 2263 nucleotide stretch demonstrates that the -70/+52 bp minimal promoter is indispensable for maintaining transcriptional activity. In addition, this minimal promoter contains a CCAAT/enhancer-binding site which is required for both the basal promoter activity and C/EBPmediated transactivation (9) . C/EBPs (CCAAT/enhancer binding proteins) are a family of transcription factors that include a highly conserved, basic-leucine zipper domain at the Cterminus for dimerization and DNA binding, and they function in regulating cellular differentiation in multiple tissues (10) (11) (12) (13) (14) (15) (16) (17) . At least six members of the family have been isolated, characterized, and they have been named , , , , , and (18) (19) (20) (21) (22) (23) .
Sequence analysis of the amelogenin minimal promoter (-70/+52) also revealed a reversed CCAAT box located in the -58/-54 region, four base pairs downstream to the C/EBP binding site. Several transcription factors are able to recognize the CCAAT box, such as CTF/NF1 (CCAAT Transcription Factor/Nuclear Factor 1) (24-26), CDP (CCAAT Displacement Protein (27-30), C/EBP (CCAAT/Enhancer Binding Protein) (20, 31, 32) , and NF-Y (Nuclear Factor-Y) (33) . Among these transcription factors, NF-Y was regarded as a leading candidate based on the following. First, of all the potential CCAATbinding proteins, only NF-Y has been shown to be absolutely required for all CCAAT pentanucleotide bona fide sequences (33) (34) (35) (36) . Second, several lines of evidence indicate that NF-Y cooperatively interacts with C/EBP to function in transcriptional regulation on a variety of promoters (37) (38) (39) . NF-Y is a heterotrimeric protein, consisting of three subunits, NF-YA (also termed CBF-B), NF-YB (CBF-A), and NF-YC (CBF-C). Alignment of amino acid sequences of these three subunits reveals several highly conserved regions. NF-YA has a glutamine-rich region, a serine/threonine-rich region, a subunit interaction domain, and a DNA-binding domain. NF-YB contains a histone-fold motif and a TBPbinding domain. Similar to NF-YB, NF-YC also bears a histone-fold motif, a TBP-binding domain, and an additional glutamine-rich region (40) . All three subunits are necessary for DNA binding. The two subunits, NF-YB and NF-YC, first form a heterodimer via their histone fold motifs. The dimer then provides a suitable docking site for NF-YA to bind to form a functionally active NF-Y heterotrimeric protein (41) .
In this study, we demonstrate that NF-Y is directly bound to the -58/-54 bp CCAAT box within the amelogenin promoter. Moreover, NF-Y and C/EBP synergistically increase the minimal amelogenin promoter activity, although NF-Y alone has only marginal effects on the promoter. We also identify protein-protein interactions between NF-Y and C/EBP . Finally, ameloblasts from developing mouse teeth in vivo express both C/EBP and NF-YA during development at a stage corresponding to maximum amelogenin expression. Taken together, these results suggest that NF-Y and C/EBP synergistically activate the mouse amelogenin gene and could contribute to the physiologic regulation of amelogenin expression during enamel formation, in vivo.
Experimental Procedures
In situ hybridization -In situ hybridization was used to determine the precise spatial distribution for amelogenin mRNA from lower incisors. An anti-sense amelogenin RNA probe was labeled by synthesis in the presence of [ 35 S] thiophosphate-UTP (New England Nuclear, Boston, MA) to specific activity of approximately 5 10 8 cpm per μg RNA. The in situ hybridization method has been previously published and used without modification (7) . Preparation of chicken anti-C/EBP antibody -A C/EBP internal epitope peptide (aa 249-263) was synthesized at the Microchemical Core Facility (University of Southern California Microchemical Core Facility), and used to generate chicken polyclonal antibodies that were purified from the yolk by affinity-chromatography to the immobilized peptide. Immunohistochemistry -Immunostaining was performed according to Couwenhoven et al. (42) , using an anti-C/EBP chicken polyclonal antibody (1:200, Invitrogen, Carlsbad, CA), or a commercially available polyclonal antibody to NF-YA (1:200, sc-10779, Santa Cruz Biotechnology, Santa Cruz, CA), followed by appropriate HRP-conjugated secondary antibodies (1:500, Zymed, San Francisco, CA). A substratechromogen mixture (Zymed, San Francisco, CA) was used for signal detection. Plasmids and cell culture -The reporter constructs of p70-luc, mC/EBP -p70-luc, and p51-luc were prepared as previously described (9) . To generate mp70-luc and mC/EBP -mp70-luc, the promoter regions were prepared by polymerase chain reactions with p70-luc as the template using a common 3'-primer (5'-TATTCTCGAG TGTATGCTCA GTGAG-3'; The Xho I site is underlined) and respective 5'-primers (5'-CGTGCTAGCT CAGAAACCTG ATCAGCTGTT CAAA-3'; and 5'-CGTGCTAGCT TCAGTCTAGA GATCAGCTGT TCAAA-3'; the Nhe I sites are underlined and the mutated site is in boldface). The PCR products were digested with Nhe I and Xho I and inserted 5' to 3' into the Nhe I-Xho I site of pGL3-Basic (Promega, Madison, WI), and verified by nucleotide sequence analysis. The expression vector for C/EBP was described previously (43) . The expression vectors for three subunits of NF-Y (NF-YA, NF-YB, NF-YC) (44) were provided by Dr. Hiroyoshi Ariga (Hokkaido University, Hokkaido, Japan). The dominant negative NF-YA expression vector (NF-YAm29) (45) was provided by Dr. Timothy Osborne (University of California at Irvine, Irvine, CA). A mouse ameloblast-like cell line LS8 was maintained as previously described (9) . Transient transfection and luciferase assayVariable amounts of plasmid DNA were used for transient transfection for each well of 12-well plates. The amount of DNA varied based upon experimental conditions and were documented in the figure legends. To normalize transfection efficiency, 75 ng of pCMV-lacZ/well was cotransfected as an internal control. The day before transfection, LS8 cells were plated in 12-well plates so that they were 50-80% confluent at the time of transfection. At the time of plating and during transfection, antibiotics were avoided. Three hours before transfection, cells were washed twice with DMEM medium and subsequently cultured in serum-free DMEM medium. Plasmid DNA (0.75 μg) was diluted into 62 μl of medium in a 5-ml Falcon culture tube, 5 μl of Plus reagent (Invitrogen, Carlsbad, CA) was added, mixed, and incubated for 15 min at room temperature. In a second tube, 2.5 μl of Lipofectamine reagent (Invitrogen, Carlsbad, CA) was diluted into 62 μl of medium and mixed. The contents of these two tubes were combined, mixed, and incubated for another 15 min at room temperature. While complexes were forming, the medium on the cells was replaced with 0.5 ml of fresh medium. The DNA-Plus-Lipofectamine complex was added to each well of cells and mixed gently. The cells were incubated for 3 h at 37°C and 5% CO 2 . After removal of the medium containing DNA-PlusLipofectamine complex, cells were incubated in 1 ml of fresh complete medium for an additional 22 h and were subject to luciferase assay with a DualLight kit (Applied Biosystems, Foster City, CA).
Cells were washed twice with phosphatebuffered saline, pH 7.4, and lysed in 100 μl of lysis buffer (100 mM potassium phosphate, pH 7.8, 0.2% Triton X-100, 0.5 mM DTT). Cell scrapers (Corning Incorporated, Acton, MA) were used to detach cells from the plate. Cell lysates were transferred to a microcentrifuge tube and centrifuged at maximum speed for 2 min. The extracts (supernatant) were transferred to a fresh tube and stored at -70°C. At the time of chemiluminescent detection, buffer A and B (Applied Biosystems, Foster City, CA) were equilibrated to room temperature and GalactonPlus Substrate was added to buffer B at the ratio 1:100. A 10 μl aliquot of cell extracts was transferred to a luminometer tube in which 25 μl of buffer A was added and immediately followed by the addition of 100 μl of buffer B. After a 15 sec delay, the luciferase signal was obtained for 5 sec in a luminometer (Lumat, Berthold, ND). After 45 min incubation at room temperature, 100 μl of Accelerator-II was added and -galactosidase signal was measured for 5 sec in the same luminometer. Preparation of nuclear extracts -LS8 cells (100-mm plates) were transiently transfected with 10 μg of C/EBP expression vector by the calcium phosphate co-precipitation method. Briefly, 10 μg of DNA was mixed with 62 μl of 2 M CaCl 2 , diluted to 500 μl with d.d.H 2 O, and added dropwise to the 37°C prewarmed 2 HBS (HEPES Buffered Saline) solution. After standing for 20 min at room temperature, the DNA-calcium phosphate co-precipitates were added dropwise to the surface of the media covering the cells and incubated overnight. The next day, medium containing the calcium phosphate was removed and replaced with fresh complete medium for additional 24 h. LS8 cells were washed twice with cold phosphate-buffered saline, pH 7.4, and by guest on October 30, 2017 http://www.jbc.org/ Downloaded from scraped off in 1 ml of hypotonic buffer (20 mM Hepes, pH 7.6, 10 mM KCl, 1 mM MgCl 2 , 0.1% Triton X-100, 20% glycerol, 2 mM phenyl methyl sulfonyl fluoride, 5 μl/ml aprotinin (Sigma, St. Louis, MO), 5 μg/ml leupeptin, 0.5 mM dithiothreitol). Cell lysates were Douncehomogenized for 15 strokes with a type A pestle on ice, transferred to a 1.5-ml tube, and centrifuged at 3,000 rpm for 5 min at 4°C. The pellet was resuspended in 100 μl of cold extraction buffer (20 mM Hepes, pH 7.6, 10 mM KCl, 1 mM MgCl 2 , 0.1% Triton X-100, 20% glycerol, 2 mM phenyl methyl sulfonyl, 5 μl/ml aprotinin (Sigma, St. Louis, MO), 5 μg/ml leupeptin, 0.5 mM dithiothreitol, 420 mM NaCl), and mixed on a rotator for 1 h at 4°C. Nuclear debris was pelleted by centrifugation at 15,000 rpm for 10 min at 4°C. Supernatants containing the nuclear extracts were frozen in liquid N 2 and stored at -80°C. The protein concentration was determined using a BioRad protein assay kit with bovine serum albumin as the standard (Bio-Rad, Hercules, CA). Electrophoresis mobility shift assay (EMSA) -The oligodeoxynucleotide probes were synthesized, annealed, and radiolabeled with [ -32 P] (PerkinElmer, Wellesley, MA) using the fill-in reaction and Klenow enzyme (Roche Molecular Biochemicals, Indianapolis, IN). A mass of 8-15 μg of nuclear extract was added from selected samples in the EMSA buffer at the final concentration of 40 mM Tris-Cl, pH 7.9, 12 mM MgCl 2 , 60 mM KCl, 2 mM EGTA, 2 mM EDTA, 25% glycerol, 0.2 μg/μl Poly(dI-dC)·poly(dI-dC), and incubated for 2 h at 4°C. Radiolabeled oligonucleotides (approximately 3,000-6,000 cpm/fmol) in 1.5 μl volume was added, incubated for additional 1 h at room temperature. Where indicated, 50-fold molar excess of unlabeled competitor probes, antibodies (1μg for anti-NF-Y, and 2 μg for anti-C/EBP , Santa Cruz Biotechnology, Santa Cruz, CA), or normal serum was included in the binding reaction prior to the addition of radiolabeled probes. After mixing with 1 μl of loading buffer containing 250 mM Tris-Cl, pH 7.5, 0.2% bromophenol blue, 0.2% xylene cyanol, and 40% glycerol, the mixture was resolved on a 5% nondenaturing polyacrylamide gel in 0.5 TBE buffer prerun at 20 mA for at least 30 min. Gel electrophoresis was carried out at 30 mA for 2.5 h. The gel was dried, and bands were visualized by autoradiography. The sequences of the oligonucleotides were as follows: wild-type (wt) sense strand, 5'-TTTTTCATTC AGAAACCTGA TTGGCTGTTC-3'; wild-type (wt) antisense strand, 5'-GAACAGCCAA TCAGGTTTCT GAATG-3'; mutant C/EBP (mC/EBP ) sense strand, 5'-TTTTTCATTC AGTCTAGAGA TTGGCTGTTC-3'; mutant C/EBP antisense strand, 5'-GAACAGCCAA TCTCTAGACT GAATG-3'; mutant NF-Y (mNF-Y) sense strand, 5'-TTTTTCATTC AGAAACCTGA TCAGCTGTTC-3'; mutant NF-Y antisense strand, 5'-GAACAGCTGA TCAGGTTTCT GAATG-3'; mutant C/EBPmutant NF-Y (mC/EBP -mNF-Y) sense strand, 5'-TTTTTCATTC AGTCTAGAGA TCAGCTGTTC-3'; mutant C/EBP -mutant NF-Y antisense strand, 5'-GAACAGCTGA TCTCTAGACT GAATG-3' (mutated nucleotides are in boldface). Co-immunoprecipitation assay and Western blotting -LS8 cells, ~90% confluent in a 100 mm cell culture plate, were washed twice in ice-cold phosphate-buffered saline. Ice-cold RIPA buffer (1 ml 1 phosphate-buffered saline, 1% Nonidet P-40, 0.1 mg/ml phenylmethylsulfonyl fluoride, 30 μl/ml aprotinin (Sigma, St. Louis, MO), and 1 mM sodium orthovanadate) was added, and the cells were collected using a cell scraper (Corning Incorporated, Acton, MA), lysed by passing six times through a 22-gauge needle at 4°C. After centrifugation at 3,000 rpm for 15 min at 4°C, the protein concentration of the supernatant was measured using a Bio-Rad protein assay kit (BioRad, Hercules, CA) with bovine serum albumin as standards. For immunoprecipitation, 500 μg of total protein was precleaned with 50 μl of protein G-agarose beads (Sigma, St. Louis, MO) prior to the addition of 2 μg of primary antibody (Santa Cruz Biotechnology, Santa Cruz, CA) for overnight incubation at 4°C with rotation. Protein G-agarose beads (20 μl; IgG binding capacity at 10-20 μg per μl) was added and incubated for 2 h at 4°C with rotation. Immunoprecipitates were collected by centrifugation at 2,500 rpm for 5 min at 4°C. The pellets were washed three times with 1 ml of phosphate-buffered saline. After the final wash, the pellets were resuspended in an equal volume of 2 SDS loading buffer, boiled for 5 min, and stored at -70°C. Samples were resolved by 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to Immobilon-P membrane (Millipore Corporate, Billerica, MA). The membranes were incubated in blocking buffer overnight at 4°C, followed by incubation with the primary antibody for 1 h and the appropriate horseradish peroxidase-conjugated secondary antibody (Amersham Biosciences, Piscataway, NJ) for 1 h at room temperature. Protein-antibody complexes were visualized by enhanced chemiluminescence (ECL, Amersham Biosciences, Piscataway, NJ).
RESULTS
Amelogenin mRNA abundance in mouse mandibular incisors -In situ hybridization studies have previously demonstrated that amelogenin mRNA level is regulated in a spatial-and temporal-restricted pattern during mouse molar tooth organogenesis (7) . In this report, we investigate the expression pattern of mouse amelogenin mRNA in lower incisors. In situ hybridization data revealed a periodicity for amelogenin mRNA by ameloblasts, ranging from low ( Figure 1A ) to high ( Figure 1D ) transcript abundance on serial sagittal sections of developing mouse incisors. This finding from mouse incisors, combined with our previous observation from mouse molars (7), suggests that amelogenin expression levels are tightly regulated at the temporal and spatial level in vivo, to accommodate the process of enamel biomineralization (5) .
Immunohistochemical localization of C/EBP and NF-YA in mouse mandibular incisors -We have previously identified C/EBP as a transactivator of amelogenin gene in vitro (9) . To investigate the relationship of C/EBP to amelogenin expression in vivo, we performed immunohistochemistry to detect C/EBP . Consistent with the amelogenin mRNA hybridization signal pattern, immunohistochemistry for C/EBP protein revealed a repeating periodicity for C/EBP with subcellular localization to either the cytoplasm or the nucleus of ameloblast cells in the mandibular incisors (Figure 2A and 2B) . Moreover, the anti-NF-YA antibody localized to the nucleus of ameloblasts from mandibular incisors ( Figure 2C and 2D). The pattern for amelogenin mRNA abundance and C/EBP /NF-YA localization within ameloblasts suggested to us a potential role for C/EBP /NF-Y in the regulation of amelogenin gene expression in vivo. We pursued the role for these transcription factors to regulate the amelogenin promoter in vitro using an ameloblastlike cell line, LS8.
The minimal amelogenin promoter activity is dependent on both the -70/-63 bp C/EBP ciselement and the -58/-54 bp CCAAT box -Deletion analysis of the mouse amelogenin promoter has shown that the -70/+51 bp region functions as a minimal promoter in LS8 cells (9) . A C/EBP ciselement is identified in the -70/-63 bp, and it is through this region that C/EBP up-regulates the promoter activity in a dose-dependent manner (9) . Sequence alignment of the -80/-40 bp of Xchromosomal amelogenin gene from mouse, pig, bovine, horse, monkey, and human revealed a highly conserved reversed CCAAT box located in the -58/-54 bp region ( Figure 3A) . All sequences showed a match for the pentanucleotides of ATTGG, a reversed CCAAT box. To investigate the potential role of this cis-element in the regulation of amelogenin promoter, the ATTGG sequence in the p70-luc reporter construct was mutated to ATCAG to generate the "mp70-luc" construct ( Figure 3B ). Transient transfection of mp70-luc into LS8 cells, compared to that of p70-luc, showed a complete loss of basal promoter activity ( Figure 3C, lane 2) . This suggested an important role for the CCAAT box for maintaining the activity of the basal amelogenin promoter. Sequence alignment also revealed that the C/EBP binding site was close to the CCAAT box, just four base pairs upstream to the CCAAT box ( Figure 3A) . To further understand the role of the C/EBP binding site and the CCAAT box in regulating the amelogenin promoter and their potential relationship with each other, a series of mutation constructs were generated as shown in Figure 3B . Each of these mutation constructs, mC/EBP -p70-luc (mutated C/EBP site), mp70-luc (mutated CCAAT site), mC/EBP -mp70-luc (mutated C/EBP site and mutated CCAAT site), and p51-luc (deleted C/EBP and deleted CCAAT sites), or their wild-type counterpart, was cotransfected into LS8 cells with or without the C/EBP expression vector, and analyzed in transient transfection assays. The mutation of the C/EBP cis-element (mC/EBP -p70-luc), CCAAT box (mp70-luc), dual mutations (mC/EBP -mp70-luc), as well as the dual deleted C/ P and CCAAT box construct (p51-luc), all showed a complete loss of the basal promoter activity ( Figure 3C, lane 2-5) . Furthermore, in response to the exogenous expression of C/EBP , the reporter activity of wild-type construct (p70-luc) was increased dramatically ( Figure 3C , lane 6), whereas the reporter activity for the remaining four altered C/EBP and/or CCAAT box constructs was greatly reduced ( Figure 3C, lane 7-10 ). The observed residual activity ( Figure 3C , lane 7-10) may be due to other factors, induced by overexpression of C/EBP , nonspecifically affecting the amelogenin promoter. Taken together, these data indicated that the integrity of the C/EBP cis-element and the reversed CCAAT box was required to maintain the basal promoter activity and C/EBP -mediated transactivation.
NF-Y is directly bound to the CCAAT box in the minimal amelogenin promoter -While a number of transcription factors are reported to recognize the CCAAT motif (20, 24, 27, 33) , subsequent analyses reveal that there is divergence in the recognition sequence of CCAAT, and that only NF-Y exclusively requires the bona fide CCAAT pentanucleotide (33) (34) (35) (36) . To test whether NF-Y was able to bind to this reversed CCAAT box in the minimal amelogenin promoter, we performed electrophoresis mobility shift assay (EMSA) using a probe bearing the C/EBP cis-element and the CCAAT motif shown in Figure 4A . As shown in Figure 4B , DNA-protein complexes formed (lane 2), and the complex could be inhibited by the addition of a 50-fold molar excess of unlabeled probe (lane 3). A rabbit antibody specific to C/EBP was able to supershift the DNA-protein complex (lane 6), a finding consistent with our previous study (9) , whereas normal rabbit serum failed to supershift the complex (lane 7). An anti-NF-Y goat antibody supershifted a substantial amount of the formed EMSA complex (lane 4), while no supershift was observed with the addition of normal goat serum (lane 5) . This data demonstrated that NF-Y was a major component of the DNA-protein complex.
Since there are only four nucleotides between these two binding sites, it is possible that the binding of one protein may interfere with the binding of the other. To investigate this possibility, four different probes were designed, each with a different combination of wild-type or mutated binding sites for C/EBP or NF-Y ( Figure 5A ). The effects of these different probes on the C/EBP and NF-Y binding were assessed by EMSA as shown in Figure 5B . 
DISCUSSION
In this study, in situ hybridization revealed a distinctive periodicity for amelogenin mRNA abundance among ameloblasts from mouse incisors at a developmental stage corresponding to maximum expression of amelogenin. Amelogenin is the most abundant protein in developing mammalian enamel and is believed to control the habit of the hydroxyapatite mineral phase (2-6). This in vivo observation prompted us to examine the amelogenin promoter for transcription factors that could significantly alter amelogenin transcript abundance. Immunohistochemistry also revealed a repeating periodicity for C/EBP and NF-YA localization within ameloblasts, suggesting a tight relationship for these transcription factors to participate in regulating amelogenin expression in vivo. These observations were the impetus for investigating the role of C/EBP and NF-Y in regulating the amelogenin promoter in vitro.
We identified highly conserved C/EBP and NF-Y binding motifs in the X-chromosomal amelogenin promoter among several mammalian species ( Figure 3A) . The integrity of both transcription factors binding motifs was critical for maintaining the activity of the basal promoter and C/EBP -mediated transactivation ( Figure 3C ). Both C/EBP and NF-Y were able to recognize their cis-elements respectively ( Figure 4B ). In addition, C/EBP and NF-Y also formed a protein-protein interaction complex ( Figure 7) . As a consequence, C/EBP and NF-Y synergistically activated the amelogenin promoter ( Figure 6 ). In contrast, NF-Y alone had only marginal effects on the promoter. C/EBP serves as a critical transcription factor during adipocyte differentiation, inducing gene expression required for fat metabolism as well as leading to the arrest of cell division (14, (46) (47) (48) (49) . While C/EBP is a transcription factor, intriguingly, its ability to arrest growth does not require its DNA-binding activity, but rather is mediated via protein-protein interactions with the cell-cycle inhibitor p21 (50), the cyclin-dependent kinases cdk2 and cdk4 (51), or E2F (52). In addition, C/EBP has been reported to stimulate promoter activity, not through its DNA binding capacity, but through its interaction with NF-Y bound to the EPHX1 CCAAT box (39) .
NF-Y is a major CCAAT-binding transcription factor that has been found to function mostly through interacting with other transcription factors (53) (54) (55) (56) (57) (58) (59) . One explanation for transcription factor pairing is that NF-Y requires its associate protein, and vice versa, in order to form a more stable complex that binds to the DNA. This may explain the mechanism of synergism observed between C/EBP with NF-Y that serve to cooperatively activate the amelogenin promoter observed in this study. However, it is also reasonable to argue that the binding of C/EBP and NF-Y to the amelogenin promoter is mutually exclusive because of the proximity of these two binding sites (four nucleotides apart). Here, EMSA data showed that both C/EBP and NF-Y were able to bind to their cognate sites respectively ( Figure Figure 5B, lane 4) . A mutant amelogenin reporter construct, mp70-luc, bearing a mutant NF-Y site and a wild-type C/EBP site showed complete loss of the basal promoter activity ( Figure 3C, lane 2) , and was also incapable of responding to the exogenous C/EBP even with its intact C/EBP cis-element ( Figure 3C, lane 7) . This suggested that NF-Y is indispensable for C/EBP -mediated transactivation of the mouse amelogenin gene.
Based on our observations, we propose a model explaining the mechanism underlying the synergism between C/EBP and NF-Y in regulating the amelogenin promoter that is shown in Figure 8 . In the presence of NF-Y bound to its cognate site, the space for C/EBP to bind to its cognate site is limited due to proximity of these two binding motifs. The C/EBP dimer adjusts its conformation to adopt a shape to fit the site, which may be favored by associating with NF-Y through protein to protein interactions (Figure 7) . Under this circumstance, the binding of C/EBP to its cognate site is perturbed ( Figure 5B , lane 5) with a conformational change that allows C/EBP domains to be exposed and hence to recruit additional transcriptional factors to ensure transcriptional synergism ( Figure 6, lane 5) . In the absence of NF-Y, C/EBP binds tightly to its cognate site ( Figure 5B, lane 15) , but with a different conformation that results in diminished transcription activation ( Figure 3C, lane 7) . In support of this model is the mouse serum albumin promoter that contains a C/EBP site tightly juxtaposed to a binding site for NF-Y, and this arrangement leads to strong synergistic activation of the serum albumin promoter (37) .
In conclusion, we demonstrate that there is a functional synergism between C/EBP and NF-Y in regulating the amelogenin gene in vitro. Both factors are required for transcriptional activation and NF-Y is indispensable for the robust expression. Furthermore, a model is proposed to explain the mechanism underlying the synergism between C/EBP and NF-Y. These data, together with our previous identification of Msx2 as a transcriptional repressor in regulating the mouse amelogenin gene expression (60) , suggest that these factors may cooperatively contribute to proper amelogenin expression in a temporally and spatially regulated fashion during tooth formation. 
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